We conducted a prospective, randomised single-blind study in 48 
A total of 51 ASA 1 and 2 patients between the ages of 16 and 45 who presented for laparoscopic gynaecological surgery were studied. Surgery was usually of short duration and consisted of laparoscopic tuballigation, brief diagnostic procedures and a small number to assess tubal patency. No patient who fulfilled the criteria was excluded. All cases were performed by the same anaesthetist working with a range of operators who used similar surgical techniques. At the preoperative visit a questionnaire was given to each patient to take home to complete and return in a stamped addressed envelope. The questionnaire contained a pain linear analogue scale and each patient was instructed in its use.
Patients were allocated to receive either thiopentone (Group A) or propofol (Group B) as their induction agent by placing the next available patient in each group in rotation until there were 25 patients in group 1 and 26 in group 2. Due to the inclusion of all eligible patients and the homogenous nature of this group of patients it was felt that this method of allocation to group did not affect the study. Patients were blinded with regard to which induction agent they received.
Patients were unpremedicated. Anaesthesia was induced in group A with thiopentone and group B with propofol sufficient to abolish the eyelash reflex. Both groups were given suxamethonium 1 mg/kg body weight to facilitate insertion of an endotracheal tube and were ventilated throughout surgery. Anaesthesia was maintained with 66070 nitrous oxide in oxygen with isoflurane and fentanyl given as required for analgesia. No other muscle relaxants were given. If patients attempted to breathe spontaneously during the procedure they were given more induction agent, the inspired concentration of volatile agent was increased and intermittent positive pressure ventilation was maintained. No lignocaine was added to the propofol as lignocaine has been reported to reduce the incidence of the myalgia. 8 Each patient was contacted by telephone between four and seven days postoperatively and given assistance with completion of the questionnaire if required. The interviewer was blinded to the induction agent used and to the order in which patients were studied.
The questionnaire asked specifically about the magnitude and nature of pain at 24, 48 and 72 hours postoperatively. Only muscular pain that was distant from the site of surgery in the chest, neck and shoulder regions were classified as suxamethonium myalgia. The severity of the pain was recorded by the patients on a linear analogue scale at 24, 48 and 72 hours postoperatively.
The results were analysed with Student's t-test and non-parametric data with Fisher's exact test.
RESULTS
Both groups were comparable for age and weight with no significant difference between them as shown in Table 1 . Three patients from group A did not return their questionnaires so were excluded from the study. The incidence of myalgia in the group who received thiopentone (Group A) was 63% compared with 19070 in the group who received propofol (Group B) as shown in There was no statistically significant difference in the severity of the pain at the operative site experienced between the two groups (Table 3 ). There was also no difference in the severity of the myalgia produced in either group (Table 4) . Only two patients experienced severe myalgia with a pain score of 9 or more out of a possible maximum of 10 on a linear analogue pain scale. Both these patients were in group A. 
DISCUSSION
This study shows that propofol effectively reduces the incidence of suxamethonium-induced myalgia compared with thiopentone. The mechanism for this effect is not understood and was not seen in a similar study in elective dental and ophthalmic surgery. 10 Propofol has been shown to possess analgesic properties that last for at least five hours postoperatively. 11 No studies have been done to look at the possibility of this analgesic effect lasting long enough to have an effect on suxamethonium myalgia but this does seem unlikely with the relatively short half-life of propofol. Propofol is also known to potentiate the muscle relaxing effect of vecuronium when given in very large doses. 12 This effect could possibly account for the protective effect of propofol in a similar manner to precurarisation.
Propofol is a free-radical scavenger resembling vitamin E and accumulates rapidly on biomembranes potentially boosting antioxidant tissue defences. 13 This effect could account for the reduction in myalgia associated with its use by reducing the amount of muscle damage incurred.
Generalised myalgia occurs with varying frequency in different groups of patients and has been shown to be more common in women. 14 The mechanism producing these pains is unknown though various theories have been suggested. Muscle spindle damage caused by calcium ion influx producing powerful muscle contraction I' raised potassium ion levels l6 and free radicals' are among the suggested causes.
We chose to use suxamethonium in this group of patients because many of these procedures were performed by a particularly fast surgeon and a single dose of suxamethonium was adequate.
The pain due to laparoscopy itself was considerable and was found to be similar in both groups. Shouldertip and abdominal pain were thought to be due to the laparoscopy so were classified as surgical pain. Aching pain in the neck, chest, and lower limbs was regarded as being related to the suxamethonium.
Suxamethonium myalgia is a difficult topic to study. The incidence is very variable, being reported at an incidence of between 0.2 and 89070. 17 Laparoscopic surgery has also been shown to be a difficult area to study. Zahl et al. showed there was no difference in the incidence of myalgia between one group of patients receiving vecuronium as the sole muscle relaxant and another group who received 3 mg of d-tubocurarine followed by suxamethonium and implicated the procedure itself. We believe that our study design removed variables between the groups and so believe our results to be due purely to an effect of the propofol.
In summary we have shown that using propofol as the induction agent reduces the incidence of suxamethonium-induced myalgia compared with thiopentone in women undergoing laparoscopy. Other factors being equal, the use of propofol as an induction agent should be considered when suxamethonium is used. The mechanism for this protection is unclear.
